NITIN PATEL: Open Payments
NPI 1770511156 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 15 payments from 10 companies in 2025. Trend: 2023 $715 · 2024 $458 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $33 |
| Corium, LLC | 1 | $31 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $14 |
Products named: CAPLYTA, Auvelity, LYBALVI, VRAYLAR, Azstarys, Jornay PM, REXULTI, FANAPT.
Industry payments across GA — which companies pay providers there.
